From protein Pop-Tarts to avocado-oil chips, a MAHA-fueled snack revolution promises healthier eating. Experts say it may ...

In every drug, there is a much larger story to tell about health and medicine and society and business and economics,” says ...

Human health in the space environment will be an important factor in these efforts. Among the concerns NASA should consider ...

Chow is an alumnus of the Epidemic Intelligence Service program (2018-2020) and serves as the president-elect for the ...

At AACR, Revolution Medicines presented more eye-catching data about its KRAS-targeting treatment, and Anthony Letai declared ...

Defense Secretary Pete Hegseth announced Tuesday that the U.S. military will no longer require all American troops to get the ...

A judge is expected to sentence OxyContin maker Purdue Pharma to forfeit $225 million to the Justice Department on Tuesday, ...

The Swiss drugmaker Roche presented the latest data for its experimental multiple sclerosis drug, setting the stage for the ...

A company that is changing the outlook on pancreatic cancer has more promising data for treatments near-term and for a ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

A one-time cell therapy from Kyverna Therapeutics for stiff person syndrome, a rare disease, improved mobility and reduced ...

Tortugas Neuroscience launched Tuesday with plans to develop drugs licensed from Chinese drugmaker Jiangsu Hansoh and ...